ImmuCell Corporation (ICCC)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| — | Q2-2026 | 8-K (2026-07-09) · 99.1 | ||
| 10-QLatest | Q1-2026 | 8-K (2026-05-14) · 99.1 | 8-K (2026-04-08) · 99.1 | ||
| 10-K/A | FY-2025 | |||
| 10-KLatest | FY-2025 | 8-K (2026-03-04) · 99.1 | 8-K (2026-01-08) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-13) · 99.1 | 8-K (2025-10-07) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-14) · 99.1 | 8-K (2025-07-09) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-14) · 99.1 | 8-K (2025-04-08) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-02-25) · 99.1 | 8-K (2025-01-10) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-13) · 99.1 | 8-K (2024-10-08) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-08-13) · 99.1 | 8-K (2024-07-09) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-05-14) · 99.1 | 8-K (2024-04-09) · 99.1 | ||
| 10-K | FY-2023 | 8-K (2024-02-27) · 99.1 | 8-K (2024-01-08) · 99.1 | ||
| 10-Q | Q3-2023 | 8-K (2023-11-13) · 99.1 | 8-K (2023-10-05) · 99.1 | ||
| 10-Q | Q2-2023 | 8-K (2023-08-10) · 99.1 | 8-K (2023-07-11) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover | ||
| Document and Entity Information | ||
| Audit Information | — |
|
| Statements | ||
| Balance Sheets | ||
| Condensed Balance Sheets (current Period Unaudited) | — |
|
| Balance Sheets (P) | ||
| Condensed Balance Sheets (current Period Unaudited) (P) | — |
|
| Condensed Statements of Income (unaudited) | — |
|
| Statements of Operations | ||
| Statements of Stockholders' Equity | ||
| Statements of Stockholders' Equity (P) | ||
| Statements of Cash Flows | ||
| Notes | ||
| Accounts Payable and Accrued Expenses | ||
| Award Timing Disclosure | — |
|
| Bank Debt | ||
| Business Operations | ||
| Cash and Cash Equivalents | ||
| Contingent Liabilities and Commitments | ||
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Employee Benefits | ||
| Income Taxes | ||
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Intangible Assets | ||
| Inventory | ||
| Note 1 | ||
| Note 10 | ||
| Note 11 | ||
| Note 12 | ||
| Note 13 | ||
| Note 14 | ||
| Note 15 | ||
| Note 16 | ||
| Note 17 | ||
| Note 18 | ||
| Note 19 | ||
| Note 2 | ||
| Note 3 | ||
| Note 4 | ||
| Note 5 | ||
| Note 6 | ||
| Note 7 | ||
| Note 8 | ||
| Note 9 | ||
| Operating Leases | ||
| Other (income) Expenses, Net | — |
|
| Other Expenses, Net | ||
| Other Income (expenses), Net | — |
|
| Pay Vs Performance Disclosure | ||
| Prepaid Expenses and Other Current Assets | ||
| Property, Plant and Equipment, Net | ||
| Related Party Transactions | ||
| Revenue | ||
| Segment Information | ||
| Stockholders Equity | ||
| Subsequent Events | ||
| Summary of Significant Accounting Policies | ||
| Trade Accounts Receivable | ||
| Trade Accounts Receivable, Net | — |
|